Piramal Group sells PEL DRG to Clarivate

▴ Piramal Group Logo
Piramal group divests DRG for 950 million dollar

Piramal group reported today, PEL DRG, a subsidiary of PEL and the holding company for Decision Resources Group (DRG) engaged in healthcare and analytics business, has signed a agreement for the sale of DRG to Clarivate Analytics, for  $950 Million (includes $900 million on closing and $50 million to be received at the end of 12 months from the date of closing). This transaction is subject to shareholder approval and is expected to be completed by end February 2020.

"PEL had initially invested $650 million in 2012 to acquire DRG, of which $260 million was infused as equity. It has realised 2.3 times its initial equity investment in rupee terms," the company said.

Commenting on the deal, Ajay Piramal, Chairman of Piramal Group, said, “Along with the ongoing equity capital raise in PEL, this transaction further strengthens the company’s balance sheet and marks another step towards significantly unlocking value in future."

Jerre Stead, Executive Chairman and CEO, Clarivate Analytics, said this is a milestone acquisition, which doubles the size of its life sciences business. "The deal is accretive to our 2020 earnings and sets us up as an essential, end-to-end, industry-leading data and analytics provider in the highly attractive Life Sciences ecosystem,” he added.

DRG caters to the information needs of pharmaceutical, insurance and hospitals, had contributed Rs 1,330.74 crore, or about 10 percent of PEL’s consolidated revenue of 13,215 crore.

Tags : #piramal #divests #sells #million #dollar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024
The Extension and Benefits of ABHA Linking with CGHS Beneficiary ID: What You Need to KnowApril 19, 2024
Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024